Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Byrne: health "moving to the EU political centre":

This article was originally published in Clinica

Executive Summary

Healthcare issues are being accorded an increasingly high profile in the EU, David Byrne, the EU Commissioner for Health and Consumer Protection, noted during his keynote speech at the launch event for the European Centre For Disease Prevention and Control (ECDC). "The last five years have seen the political profile of health policy steadily increase. Health has steadily moved from the margins to the centre of the EU's political agenda," he said, addressing senior health officials and politicians from around Europe, North America and Asia. The ECDC, which will among other things act as an EU epidemiological surveillance point and round-the-clock early warning and response system with the availability of specialists in communicable diseases, is due to start work in May next year. See also Clinica No 1125, p 9.

You may also be interested in...

Cosmetic And Personal Care Trademark Review 24 November, 2020

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

CBD Health Benefits More Attractive To Women? FDA Prioritizes Research Into Utero Effects

Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA  neuroscientist Andrew Shen.

COVID-19 Serology Templates: FDA Updates Sponsor Template, Adds Home Test Document

The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts